机译:肺癌腺癌患者的促进淋巴瘤激酶(ALK)突变
Univ Malaya Fac Med Dept Pathol Kuala Lumpur Malaysia;
Univ Malaya Fac Med Dept Pathol Kuala Lumpur Malaysia;
Univ Malaya Fac Med Dept Pathol Kuala Lumpur Malaysia;
Univ Malaya Fac Med Dept Med Kuala Lumpur Malaysia;
Univ Malaya Fac Med Dept Med Kuala Lumpur Malaysia;
Subang Jaya Med Ctr Selangor Malaysia;
Subang Jaya Med Ctr Selangor Malaysia;
ALK; non-small cell lung cancer;
机译:肺癌腺癌患者的促进淋巴瘤激酶(ALK)突变
机译:Relationship between molecular changes in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations in lung adenocarcinoma
机译:Relationship between molecular changes in epidermal growth factor receptor(EGFR)and anaplastic lymphoma kinase(ALK)mutations in lung adenocarcinoma
机译:接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
机译:ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
机译:对克唑替尼耐药的ALK(间变性淋巴瘤激酶)阳性肺腺癌患者同时发生EGFR(表皮生长因子受体)和KRAS(V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物)突变
机译:对克唑替尼具有耐药性的ALK(间变性淋巴瘤激酶)阳性肺腺癌患者同时发生EGFR(表皮生长因子受体)和KRAS(V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物)突变